Senior insider sale
Chief Financial Officer at TRAWS PHARMA, INC. — senior position signals high conviction
$4.0K
5.03K shares
What this filing means
GUERIN MARK PATRICK plans to sell 5.03K shares of TRAWS PHARMA, INC. valued at approximately $4.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/14/2024ACC: 0001950047-24-002325
Officer· Chief Financial Officer
Since Jul 2018
5.03K
Shares to sell
$4.0K
Approx. market value
2.59K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted stock vesting under a registered plan
Not Applicable
3/13/2024
2.59KTotal acquired2.59K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/13/2024 | Restricted stock vesting under a registered plan Not Applicable | 2.59K | — |
| Total | 2.59K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
2.44K
Market value
$1.6K
2/8/2024
Planned — Approximate Date
NASDAQPlanned
Units to sell
2.59K
Market value
$2.3K
3/14/2024
Total
Units
5.03K
Value
$4.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/8/2024 | 2.44K | $1.6K | — | Completed |
| Planned — Approximate Date | ||||
3/14/2024 | 2.59K | $2.3K | NASDAQ | Planned |
| Total | 5.03K | $4.0K | ||